Overview

This is a randomized clinical trial that will be carried out in women with endometriosis divided into two groups: the experimental group (EG) that will receive therapeutic-educational physiotherapy, which will combine therapeutic exercise with a pain education program, and the control group (CG) who will receive the pain education program.

The participants will be evaluated at three moments: before starting the study (T1), after the 8-week treatment program (T2) and after another 8 weeks of follow-up in which they will be encouraged to continue with the treatment (T3). The initial assessment will include a medical and physiotherapy history, and at T1, T2 and T3 the following will be assessed: pain, abdominopelvic mobility, muscle status, functionality, sexual function, quality of life, stress and biomarkers of chronic inflammation.

Eligibility

Inclusion Criteria:

• Diagnosis of endometriosis made by imaging techniques (MRI or ultrasound) or by surgery.
• A period of 3 months or more since the last surgery if they have undergone surgery.
• Who are receiving hormone treatment and have their disease under control.
• Persistent pelvic pain for at least 3 months.
• With pain and hypertonus in the pelvic musculature, myofascial syndrome, vestibulodynia or pudendal neuropathy.
• Consent to participate in the study
• Capable of carrying out the follow-up of the study until the final visit.
• Who have audiovisual resources and the internet at their disposal.

Exclusion Criteria:

• Women in the menopausal phase
• Women undergoing fertility treatment or planning to undergo fertility treatment in the next 3 months.
• Pregnant women.
• Women undergoing physiotherapy treatment or who have undergone physiotherapy treatment in the last 3 months.
• Having suffered a fracture in the last 3 months in the lower limb that limits their functional capacity.
• Cognitive illness that prevents correct comprehension of the exercises.
• Musculoskeletal pathology or neuropathy in acute phase.
• Having suffered or suffering from a neoplastic disease.
• Untreated endometriosis
• Acquired genital abnormalities of the pelvis or pelvic floor.
• Women in a situation of litigation or economic compensation, or pending the granting of a degree of disability.
• Severe mental illness (schizophrenia, borderline personality disorder, etc.)